US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

39.45

-0.5550-1.39%

Volume:464.46K

Turnover:18.31M

Market Cap:1.13B

PE:-20.78

High:40.50

Open:40.00

Low:38.82

Close:40.00

52wk High:41.70

52wk Low:16.54

Shares:28.52M

Float Shares:13.13M

Volume Ratio:1.08

T/O Rate:3.54%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8984

EPS(LYR):-2.3387

ROE:-26.25%

ROA:-18.44%

PB:5.45

PE(LYR):-16.87

Loading ...

Overview Company News Filings

Werewolf Therapeutics Is Maintained at Buy by B of A Securities

Dyne Therapeutics Raised to Strong Buy From Outperform by Raymond James

What's Going On With Coya Therapeutics Stock?

Benzinga_recent_news

Qyuns Therapeutics Completes Successful Placement of New H Shares

LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences

Coya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Raymond James Upgrades Dyne Therapeutics to Strong Buy From Outperform, Adjusts Price Target to $35 From $31

MT Newswires Live

Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences

Dyne Therapeutics upgraded to Strong Buy from Outperform at Raymond James

HighTide Therapeutics Reports Promising Interim Results for 2025

Arovella Therapeutics to Quote New Securities on ASX

Defence Therapeutics Launches $1.2 Million Debenture Units Financing

BriaCell Therapeutics trading halted, news pending

Decoy Therapeutics Reports Financial Downturn Amid Funding Challenges

CERo Therapeutics Hldgs Q2 EPS $(61.71) Misses $(11.21) Estimate

Serina Therapeutics Amends Bylaws for Governance Transparency

Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025

Arovella Therapeutics Full Year 2025 Earnings: AU$0.007 loss per share (vs AU$0.009 loss in FY 2024)

Simply Wall St.

Arcturus Therapeutics Is Maintained at Outperform by Leerink Partners

Summit Therapeutics put volume heavy and directionally bearish

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":39.445,"timestamp":1756147654819,"preClose":40,"halted":0,"volume":464458,"delay":0,"floatShares":13134810,"shares":28522096,"eps":-1.898372,"marketStatus":"Trading","change":-0.555,"latestTime":"08-25 14:47:43 EDT","open":40,"high":40.5,"low":38.815,"amount":18306318.532544002,"amplitude":0.042125,"askPrice":39.49,"askSize":34,"bidPrice":39.36,"bidSize":313,"shortable":3,"etf":0,"ttmEps":-1.898372,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756152000000},"marketStatusCode":2,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":40,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":40,"latestTime":"09:27 EDT","volume":300800,"amount":12031724.467200002,"timestamp":1756128420047},"postHourTrading":{"tag":"盘后","latestPrice":39.93,"preClose":40,"latestTime":"19:43 EDT","volume":11384,"amount":455269.04,"timestamp":1755906219984},"volumeRatio":1.076858,"impliedVol":0.8522,"impliedVolPercentile":0.7263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":13134810,"roa":"-18.44%","roe":"-26.25%","lyrEps":-2.338654,"volumeRatio":1.076858,"shares":28522096,"dividePrice":0,"high":40.5,"amplitude":0.042125,"preClose":40,"low":38.815,"week52Low":16.535,"pbRate":"5.45","psRate":"225.01","week52High":41.7,"institutionHeld":0,"latestPrice":39.445,"committee":0.804035,"eps":-1.898372,"divideRate":0,"volume":464458,"delay":0,"ttmEps":-1.898372,"open":40,"prevYearClose":28.87,"prevWeekClose":40,"prevMonthClose":29.77,"prevQuarterClose":29.31,"fiveDayClose":38.77,"twentyDayClose":31.51,"sixtyDayClose":29.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-30","symbol":"LENZ","fiscalQuarterEnding":"2025/06","expectedEps":-0.58,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-08-22","current":-21.691773,"percent":0.002985,"low":-22.268769,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"high":-5.069183,"avg":-11.98188,"sd":4.459531,"marketCap":1136605525},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543},{"date":"2025-07-25","current":-19.691695,"twenty":-16.100113,"median":-11.044571,"eighty":-7.492045,"marketCap":940081543},{"date":"2025-08-01","current":-16.20487,"twenty":-16.158905,"median":-11.077981,"eighty":-7.667213,"marketCap":849102797},{"date":"2025-08-08","current":-17.484059,"twenty":-16.20487,"median":-11.141188,"eighty":-7.667213,"marketCap":916129723},{"date":"2025-08-15","current":-22.268769,"twenty":-16.33076,"median":-11.193196,"eighty":-7.674511,"marketCap":1166838947},{"date":"2025-08-22","current":-21.691773,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"marketCap":1136605525}],"updateTime":1756120956215},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562295532","title":"Werewolf Therapeutics Is Maintained at Buy by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2562295532","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562295532?lang=en_us&edition=fundamental","pubTime":"2025-08-26 01:05","pubTimestamp":1756141500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HOWL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 25, 2025 13:05 ET (17:05 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOWL","LENZ"],"gpt_icon":0},{"id":"2562287242","title":"Dyne Therapeutics Raised to Strong Buy From Outperform by Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2562287242","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562287242?lang=en_us&edition=fundamental","pubTime":"2025-08-25 22:57","pubTimestamp":1756133820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DYN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 25, 2025 10:57 ET (14:57 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","RJF","DYN"],"gpt_icon":0},{"id":"2562082247","title":"What's Going On With Coya Therapeutics Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2562082247","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562082247?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:57","pubTimestamp":1756130220,"startTime":"0","endTime":"0","summary":"Shares of Coya Therapeutics are trading higher Monday morning. The company provided an update regarding the development of a new treatment for Amyotrophic Lateral Sclerosis.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/25/Sonnet-BioTherapeutics-Inc-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/25/Sonnet-BioTherapeutics-Inc-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/08/47308520/whats-going-on-with-coya-therapeutics-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2562824793","title":"Qyuns Therapeutics Completes Successful Placement of New H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2562824793","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562824793?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:40","pubTimestamp":1756129205,"startTime":"0","endTime":"0","summary":"The latest update is out from Qyuns Therapeutics Co., Ltd. Class H ( ($HK:2509) ). Qyuns Therapeutics Co., Ltd. has successfully completed the plac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-completes-successful-placement-of-new-h-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-completes-successful-placement-of-new-h-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2562224978","title":"LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2562224978","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562224978?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:00","pubTimestamp":1756123200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Aug.  25, 2025  (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalm","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/25/3138414/0/en/LENZ-Therapeutics-to-Present-at-Upcoming-Investor-and-Medical-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","BK4127","LU1732799900.SGD","LU2028103732.USD","LU0912757837.SGD","LU0314104364.USD","LU1989772840.SGD","LU1162221912.USD","LU2347655156.SGD","BK4585","IE00BKVL7J92.USD","LU2111349929.HKD","LU1720051017.SGD","IE00BZ1G4Q59.USD","BK4007","LU0158827781.USD","BK4534","LU0158827948.USD","LU2023251221.USD","LU0225283273.USD","LU0098860793.USD","LU1720051108.HKD","BK4588","LU0234570918.USD","LU1732800096.USD","LU2089284900.SGD","LU0971096721.USD","BK4139","LENZ","LU1989772923.USD","LU0267386448.USD","LU1244550577.SGD","LU1244550494.USD","LU1244550221.USD","LU0106831901.USD","LU2089283258.USD","LU1363072403.SGD","LU0006306889.USD","LU1668664300.SGD","BK4504","LU1548497426.USD","BK4539","LU2133065610.SGD","LU2271345857.HKD","LU0320765646.SGD","LU0882574139.USD","BK4581","BK4516","LU0795875169.SGD","LU0795875086.SGD"],"gpt_icon":0},{"id":"2562466262","title":"Coya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2562466262","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562466262?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:35","pubTimestamp":1756121700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COYA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 25, 2025 07:35 ET (11:35 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","COYA"],"gpt_icon":0},{"id":"2562582246","title":"Raymond James Upgrades Dyne Therapeutics to Strong Buy From Outperform, Adjusts Price Target to $35 From $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2562582246","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562582246?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:29","pubTimestamp":1756121388,"startTime":"0","endTime":"0","summary":"Dyne Therapeutics Inc (DYN) has an average rating of buy and mean price target of $35.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","RJF","DYN"],"gpt_icon":0},{"id":"2562124579","title":"Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2562124579","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562124579?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:00","pubTimestamp":1756119600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Aug.  25, 2025  (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/25/3138338/0/en/Beam-Therapeutics-to-Participate-in-Upcoming-September-2025-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2562248357","title":"Dyne Therapeutics upgraded to Strong Buy from Outperform at Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2562248357","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562248357?lang=en_us&edition=fundamental","pubTime":"2025-08-25 18:10","pubTimestamp":1756116617,"startTime":"0","endTime":"0","summary":"Raymond James upgraded Dyne Therapeutics (DYN) to Strong Buy from Outperform with a $35 price target Published first on TheFly – the ultimate sourc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dyne-therapeutics-upgraded-to-strong-buy-from-outperform-at-raymond-james-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dyne-therapeutics-upgraded-to-strong-buy-from-outperform-at-raymond-james-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DYN","RJF","LENZ"],"gpt_icon":0},{"id":"2562041211","title":"HighTide Therapeutics Reports Promising Interim Results for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2562041211","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562041211?lang=en_us&edition=fundamental","pubTime":"2025-08-25 16:38","pubTimestamp":1756111104,"startTime":"0","endTime":"0","summary":"An announcement from Hightide Therapeutics Inc ( ($HK:2511) ) is now available. HighTide Therapeutics announced its unaudited consolidated interim ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hightide-therapeutics-reports-promising-interim-results-for-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hightide-therapeutics-reports-promising-interim-results-for-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2562213334","title":"Arovella Therapeutics to Quote New Securities on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2562213334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562213334?lang=en_us&edition=fundamental","pubTime":"2025-08-25 14:07","pubTimestamp":1756102055,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Limited ( ($AU:ALA) ) has shared an announcement. Arovella Therapeutics Limited announced the quotation of 3,043,478 ordinary...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arovella-therapeutics-to-quote-new-securities-on-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arovella-therapeutics-to-quote-new-securities-on-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2561284345","title":"Defence Therapeutics Launches $1.2 Million Debenture Units Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2561284345","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561284345?lang=en_us&edition=fundamental","pubTime":"2025-08-23 09:02","pubTimestamp":1755910949,"startTime":"0","endTime":"0","summary":"Defence Therapeutics ( ($TSE:DTC) ) has shared an update. Defence Therapeutics Inc. has announced a non-brokered private placement of debenture uni...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-launches-1-2-million-debenture-units-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-launches-1-2-million-debenture-units-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2561289663","title":"BriaCell Therapeutics trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2561289663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561289663?lang=en_us&edition=fundamental","pubTime":"2025-08-23 07:55","pubTimestamp":1755906909,"startTime":"0","endTime":"0","summary":"19:50 EDT BriaCell (BCTX) Therapeutics trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-therapeutics-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-therapeutics-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2561228680","title":"Decoy Therapeutics Reports Financial Downturn Amid Funding Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2561228680","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561228680?lang=en_us&edition=fundamental","pubTime":"2025-08-23 05:53","pubTimestamp":1755899611,"startTime":"0","endTime":"0","summary":"An announcement from Salarius Pharmaceuticals ( ($SLRX) ) is now available. Decoy Therapeutics, Inc. reported a significant financial downturn for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/decoy-therapeutics-reports-financial-downturn-amid-funding-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/decoy-therapeutics-reports-financial-downturn-amid-funding-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2561283908","title":"CERo Therapeutics Hldgs Q2 EPS $(61.71) Misses $(11.21) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2561283908","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561283908?lang=en_us&edition=fundamental","pubTime":"2025-08-23 05:20","pubTimestamp":1755897600,"startTime":"0","endTime":"0","summary":"CERo Therapeutics Hldgs (NASDAQ:CERO) reported quarterly losses of $(61.71) per share which missed the analyst consensus estimate of $(11.21) by 450.74 percent. This is a 79.59 percent increase over losses of $(302.32)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47295105/cero-therapeutics-hldgs-q2-eps-61-71-misses-11-21-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CERO"],"gpt_icon":0},{"id":"2561885782","title":"Serina Therapeutics Amends Bylaws for Governance Transparency","url":"https://stock-news.laohu8.com/highlight/detail?id=2561885782","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561885782?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:31","pubTimestamp":1755894701,"startTime":"0","endTime":"0","summary":"Serina Therapeutics ( ($SER) ) has issued an announcement. On August 18, 2025, Serina Therapeutics‘ Board of Directors amended the company’s bylaws...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/serina-therapeutics-amends-bylaws-for-governance-transparency?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/serina-therapeutics-amends-bylaws-for-governance-transparency?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2561728865","title":"Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2561728865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561728865?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:28","pubTimestamp":1755894486,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics ( ($CMMB) ) has shared an update. Chemomab Therapeutics Ltd. announced a change in the ratio of its American Depositary Share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chemomab-therapeutics-announces-ads-ratio-change-effective-august-26-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chemomab-therapeutics-announces-ads-ratio-change-effective-august-26-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2561887782","title":"Arovella Therapeutics Full Year 2025 Earnings: AU$0.007 loss per share (vs AU$0.009 loss in FY 2024)","url":"https://stock-news.laohu8.com/highlight/detail?id=2561887782","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561887782?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:21","pubTimestamp":1755894079,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics ( ASX:ALA ) Full Year 2025 Results Key Financial Results Net loss: AU$7.51m (loss narrowed by 14...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ala/arovella-therapeutics-shares/news/arovella-therapeutics-full-year-2025-earnings-au0007-loss-pe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","ALA.AU"],"gpt_icon":0},{"id":"2561406679","title":"Arcturus Therapeutics Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2561406679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561406679?lang=en_us&edition=fundamental","pubTime":"2025-08-22 23:45","pubTimestamp":1755877500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 22, 2025 11:45 ET (15:45 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ARCT"],"gpt_icon":0},{"id":"2561403008","title":"Summit Therapeutics put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2561403008","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561403008?lang=en_us&edition=fundamental","pubTime":"2025-08-22 22:55","pubTimestamp":1755874509,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Summit Therapeutics (SMMT) with 1,584 puts trading, or 2x expected. Most active are 9/5 weekly 26 puts and Sep-25 19 puts, wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-put-volume-heavy-and-directionally-bearish-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-put-volume-heavy-and-directionally-bearish-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SMMF","LU2488822045.USD","SMMT","BK4539","BK4211","BK4007","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":1,"totalSize":328,"code":"91000000","status":"200"}]}}